|
1
|
Kemp CD and Conte JV: The pathophysiology
of heart failure. Cardiovasc Pathol. 21:365–371. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lau DH, Schotten U, Mahajan R, Antic NA,
Hatem SN, Pathak RK, Hendriks JM, Kalman JM and Sanders P: Novel
mechanisms in the pathogenesis of atrial fibrillation: Practical
applications. Eur Heart J. 37:1573–1581. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Verheule S, Eckstein J, Linz D, Maesen B,
Bidar E, Gharaviri A and Schotten U: Role of endo-epicardial
dissociation of electrical activity and transmural conduction in
the development of persistent atrial fibrillation. Prog Biophys Mol
Biol. 115:173–185. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Robinson E, Cassidy RS, Tate M, Zhao Y,
Lockhart S, Calderwood D, Church R, McGahon MK, Brazil DP,
McDermott BJ, et al: Exendin-4 protects against post-myocardial
infarction remodelling via specific actions on inflammation and the
extracellular matrix. Basic Res Cardiol. 110(20)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM,
Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M and Drucker
DJ: GLP-1R agonist liraglutide activates cytoprotective pathways
and improves outcomes after experimental myocardial infarction in
mice. Diabetes. 58:975–983. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
DeNicola M, Du J, Wang Z, Yano N, Zhang L,
Wang Y, Qin G, Zhuang S and Zhao TC: Stimulation of glucagon-like
peptide-1 receptor through exendin-4 preserves myocardial
performance and prevents cardiac remodeling in infarcted
myocardium. Am J Physiol Endocrinol Metab. 307:E630–E643.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bao W, Aravindhan K, Alsaid H, Chendrimada
T, Szapacs M, Citerone DR, Harpel MR, Willette RN, Lepore JJ and
Jucker BM: Albiglutide, a long lasting glucagon-like peptide-1
analog, protects the rat heart against ischemia/reperfusion injury:
Evidence for improving cardiac metabolic efficiency. PLoS One.
6(e23570)2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Richards P, Parker HE, Adriaenssens AE,
Hodgson JM, Cork SC, Trapp S, Gribble FM and Reimann F:
Identification and characterization of GLP-1 receptor-expressing
cells using a new transgenic mouse model. Diabetes. 63:1224–1233.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen J, Wang D, Wang F, Shi S, Chen Y,
Yang B, Tang Y and Huang C: Exendin-4 inhibits structural
remodeling and improves Ca2+ homeostasis in rats with heart failure
via the GLP-1 receptor through the eNOS/cGMP/PKG pathway. Peptides.
90:69–77. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Iwasa M, Kobayashi H, Yasuda S, Kawamura
I, Sumi S, Yamada Y, Shiraki T, Yamaki T, Ushikoshi H, Aoyama T, et
al: Antidiabetic drug voglibose is protective against
ischemia-reperfusion injury through glucagon-like peptide 1
receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric
oxide synthase pathway in rabbits. J Cardiovasc Pharmacol.
55:625–634. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wende AR, O'Neill BT, Bugger H, Riehle C,
Tuinei J, Buchanan J, Tsushima K, Wang L, Caro P, Guo A, et al:
Enhanced cardiac Akt/protein kinase B signaling contributes to
pathological cardiac hypertrophy in part by impairing mitochondrial
function via transcriptional repression of mitochondrion-targeted
nuclear genes. Mol Cell Biol. 35:831–846. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Basalay MV, Mastitskaya S, Mrochek A,
Ackland GL, Del AA, Sanchez J, Sjoquist PO, Pernow J, Gourine AV
and Gourine A: Glucagon-like peptide-1 (GLP-1) mediates
cardioprotection by remote ischaemic conditioning. Cardiovasc Res.
112:669–676. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals. Guide for the Care and Use of Laboratory Animals. 8th
edition. Washington (DC): National Academies Press (US), 2011.
|
|
14
|
Yamamoto H, Lee CE, Marcus JN, Williams
TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB,
Drucker DJ and Elmquist JK: Glucagon-like peptide-1 receptor
stimulation increases blood pressure and heart rate and activates
autonomic regulatory neurons. J Clin Invest. 110:43–52.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Sisley S, Smith K, Sandoval DA and Seeley
RJ: Differences in acute anorectic effects of long-acting GLP-1
receptor agonists in rats. Peptides. 58:1–6. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang D, Liu T, Shi S, Li R, Shan Y, Huang
Y, Hu D and Huang C: Chronic administration of catestatin improves
autonomic function and exerts cardioprotective effects in
myocardial infarction rats. J Cardiovasc Pharmacol Ther.
21:526–535. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Amino M, Yoshioka K, Tanabe T, Tanaka E,
Mori H, Furusawa Y, Zareba W, Yamazaki M, Nakagawa H, Honjo H, et
al: Heavy ion radiation up-regulates Cx43 and ameliorates
arrhythmogenic substrates in hearts after myocardial infarction.
Cardiovasc Res. 72:412–421. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nattel S: Molecular and cellular
mechanisms of atrial fibrosis in atrial Fibrillation. JACC Clin
Electrophysiol. 3:425–435. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen J, Xu S, Zhou W, Wu L, Wang L and Li
W: Exendin-4 reduces ventricular arrhythmia activity and calcium
sparks-mediated sarcoplasmic reticulum Ca Leak in rats with heart
failure. Int Heart J. 61:145–152. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lee TM, Chen WT and Chang NC: Sitagliptin
decreases ventricular arrhythmias by attenuated glucose-dependent
insulinotropic polypeptide (GIP)-dependent resistin signalling in
infarcted rats. Biosci Rep. 36(e00307)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chinda K, Palee S, Surinkaew S,
Phornphutkul M, Chattipakorn S and Chattipakorn N: Cardioprotective
effect of dipeptidyl peptidase-4 inhibitor during
ischemia-reperfusion injury. Int J Cardiol. 167:451–457.
2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Huang JH, Chen YC, Lee TI, Kao YH, Chazo
TF, Chen SA and Chen YJ: Glucagon-like peptide-1 regulates calcium
homeostasis and electrophysiological activities of HL-1
cardiomyocytes. Peptides. 78:91–98. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li D, Melnyk P, Feng J, Wang Z, Petrecca
K, Shrier A and Nattel S: Effects of experimental heart failure on
atrial cellular and ionic electrophysiology. Circulation.
101:2631–2638.22. 2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li D, Fareh S, Leung TK and Nattel S:
Promotion of atrial fibrillation by heart failure in dogs: Atrial
remodeling of a different sort. Circulation. 100:87–95.
1999.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lammers WJ, Schalij MJ, Kirchhof CJ and
Allessie MA: Quantification of spatial inhomogeneity in conduction
and initiation of reentrant atrial arrhythmias. Am J Physiol.
259:H1254–H1263. 1990.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jalife J and Kaur K: Atrial remodeling,
fibrosis, and atrial fibrillation. Trends Cardiovasc Med.
25:475–484. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Vigmond E, Pashaei A, Amraoui S, Cochet H
and Hassaguerre M: Percolation as a mechanism to explain atrial
fractionated electrograms and reentry in a fibrosis model based on
imaging data. Heart Rhythm. 13:1536–1543. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Purnomo Y, Piccart Y, Coenen T, Prihadi JS
and Lijnen PJ: Oxidative stress and transforming growth
factor-β1-induced cardiac fibrosis. Cardiovasc Hematol Disord Drug
Targets. 13:165–172. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhao W, Zhao T, Chen Y, Ahokas RA and Sun
Y: Oxidative stress mediates cardiac fibrosis by enhancing
transforming growth factor-beta1 in hypertensive rats. Mol Cell
Biochem. 317:43–50. 2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tate M, Robinson E, Green BD, McDermott BJ
and Grieve DJ: Exendin-4 attenuates adverse cardiac remodelling in
streptozocin-induced diabetes via specific actions on infiltrating
macrophages. Basic Res Cardiol. 111(1)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS,
Drucker DJ and Husain M: Cardioprotective and vasodilatory actions
of glucagon-like peptide 1 receptor are mediated through both
glucagon-like peptide 1 receptor-dependent and -independent
pathways. Circulation. 117:2340–2350. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Condorelli G, Drusco A, Stassi G,
Bellacosa A, Roncarati R, Iaccarino G, Russo MA, Gu Y, Dalton N,
Chung C, et al: Akt induces enhanced myocardial contractility and
cell size in vivo in transgenic mice. Proc Natl Acad Sci USA.
99:12333–12338. 2002.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Abdalla M, Sabbineni H, Prakash R, Ergul
A, Fagan SC and Somanath PR: The Akt inhibitor, triciribine,
ameliorates chronic hypoxia-induced vascular pruning and
TGFβ-induced pulmonary fibrosis. Br J Pharmacol. 172:4173–4188.
2015.PubMed/NCBI View Article : Google Scholar
|
